(2) Plan for the 30 years after retirement and move towards the 120th birthday celebration.

  Disease prevention, health preservation, and longevity will be a trillion-dollar market. In the next 5 to 10 years, it will be very important for people who want to live longer, for drug research and development institutions, and for health care institutions that provide services. Because in these 5 to 10 years, many high-quality health products, early diagnosis, vaccine drugs, biological cells, gene therapy, surgical instrument treatment, medical devices, and health care services will be quickly developed, produced, and put into use with the help of AI, and people's life expectancy will be greatly extended. I hope that we can all enter this field, take what we need, cooperate and develop, and welcome the arrival of the singularity of medical technology. Live a healthy and happy life for many years, and then possibly live to 100 years old or longer, plan for the 30 years after retirement, and continue to contribute to society!

We plan:

I. Establish a health and longevity club
We will focus on the medical, health and wellness progress related to the health of members, provide health consultation services to members, assist and escort members to live healthily for many years, welcome the arrival of the singularity of medical technology, and then may live to 100 years old or longer, plan for the 30 years after retirement, and continue to contribute to society!
Please join the health and longevity club

II. Health and longevity venture capital project:
Health and longevity venture capital project

Cooperate with venture capitalists to develop high-quality marketed medicine, food, nutrition and health care products, stem cells and exosomes, engineered protein antiviral and tumor vaccines, serving the young, middle-aged and elderly population and helping to protect their lives for more than 10 years.

  Overview: The Lancet reported that in 2021, about 3 billion people in the world will be affected by neurological diseases. China reported that there are about 17 million patients with Alzheimer's disease, more than 3 million with Parkinson's disease, and more than 60,000 patients with ALS, the most incurable disease. Although there are no effective treatments at present, the rapidly emerging stem cell therapy has brought hope for this! By the end of 2024, 130 new stem cell drugs have applied for new drug clinical trials in China, and the nervous system accounts for 25%; According to the guidance of the two sessions, China will increase policy encouragement and large-scale financial support for the field of biological cells, making China one of the world's leaders.

  We hope to obtain venture capital (8-15% stake) to support our research and development of ALS with human induced stem cell exosomes (as a clinical trial project with rapid approval); at the same time, we will initiate animal model treatment research on other neurological diseases (acute and chronic cerebral stroke, Alzheimer's disease, Parkinson's disease, acute and chronic spinal cord injury, etc.) using human induced stem cell exosomes. Any success will accelerate the clinical trial research on neurological diseases; enable our company to quickly catch up and become a leading biological cell therapy company, attract a large number of people seeking treatment at home and abroad to the local area, and promote local economic prosperity.